ylliX - Online Advertising Network
Company Ticker News

GlaxoSmithKline and Sanofi plan to submit data from COVID-19 booster and Phase III trials for approval

GlaxoSmithKline and Sanofi plan to submit data from COVID-19 booster and Phase III trials for approval

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory applications for a COVID-19 vaccine. The companies are in talks with regulatory authorities, including the US Food & Drug Administration and the European Medicines Agency.

...read full article on Proactive Investors

ylliX - Online Advertising Network